ArticleJournal of internal medicine2025

Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes.

Hashmat Sayed Zohori Bahrami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.